Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
Clinical trial NCT03626896 · COMPLETED
Trial details
- NCT number
- NCT03626896
- Sponsor
- NaviFUS Corporation
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-17
- Primary completion
- 2019-05-20
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.